Polaryx Therapeutics, Inc. Total Current Liabilities increased by 67.6% to $1.01M in Q1 2026 compared to the prior quarter. This increase may warrant attention — for this metric, lower values are generally preferred.
A rising trend relative to current assets may indicate tightening liquidity or increased operational leverage.
The sum of all financial obligations and debts that are due to be settled within one year or one operating cycle. This i...
Used in the calculation of the Current Ratio and Quick Ratio to assess a firm's short-term financial health relative to industry peers.
total_current_liabilities| Q4 '25 | Q1 '26 | |
|---|---|---|
| Value | $605.00K | $1.01M |
| QoQ Change | — | +67.6% |